Effects of neuroendocrine obesity induction on systemic hemodynamics and left ventricular function of normotensive rats;Efeito da indução de obesidade neuroendócrina sobre a hemodinâmica sistémica e a função ventricular esquerda de ratos normotensos

Arquivos Brasileiros de Endocrinologia e Metabologia

Volumn 52, Issue 1, 2008, Pages 47-54

  Voltera, Alina F ^a,b   Cesaretti, Mário L R ^a   Ginoza, Milton ^a   Kohlmann Jr , Osvaldo ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b NONE   (Brazil)

Author keywords

Heart function; Monosodium glutamate; Obesity; Systemic hemodynamics; Visceral fat

Indexed keywords

EID: 41149123244     PISSN: 00042730     EISSN: 16779487     Source Type: Journal    
DOI: 10.1590/s0004-27302008000100008     Document Type: Article

References (25)

1. WHO -World Health Organization, Obesity- preventing and managing the global epidemic. Geneva: Report of a WHO Consultation on Obesity; 1998.
2. Popkin BM, Doak CM. The obesity epidemic is a worldwide phenomenon. Nutr ver. 1998;56(4 Pt 1):106-14.
3. Pereira LO, Francischi RP, Klopfer M, Sawada JA, Santos R, Vieira P et al. Obesidade e suas implicações -Ação da atividade física e controle nutricional. Rev Bras Nutr Clin. 1999;14:9-17.
4. Reaven GM. Role of insulin resistance in human disease. Diabetes. 1988;37:1495-507.
5. DeFronzo RA, Ferrannini E. Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia and atherosclerotic cardiovascular disease. Diabetes Care. 1991;14(3):173-94.
6. Jonsson S, Hedblad B, Engstrom G, Nilsson P, Berglund G, Janzon L. Influence os obesity on cardiovascular risk. Twenty-three-year follow-uppf22025menfroman urban Swedish population. Int J Obes Relat Metab Disord. 2002;26(8):1046-53.
7. Kannel WB, Cupples LA, Ramaswami R, Stokes III, Kreger BE, Higgins M. Regional obesity and risk of cardiovascular disease; the Framingham Study. J Clin Epidemiol. 1991;44(2):183-90.
8. Lapidus L, Bengtsson C, Larsson B. Distribution of adipose tissue and risk of cardiovascular disease and death: a 12-year follow-up of participants in the population study of women in Gotthenburg, Sweden. BMJ. 1984;289:1257-61.
9. Carneiro G, Faria NA, Ribeiro Filho FF, Lerario D, Ferreira SR, Zanella MT. Influence of body fat distribution on the prevalence of arterial hypertension and other cardiovascular risk factors in obese patients. Rev Assoc Med Bras. 2003;49(3):306-11.
10. Gillum RF, Mussolino ME, Madans JH. Body fat distribution and hypertension incidence in women and men. The NHANES I Epidemiologic Follow-up Study. Int J Obes Realt Metab Disord. 1998;22(2):127-34.
11. Mark AL, Correia M, Morgan DA, Shaffer RA, Haynes WG. State-of-the-art-lecture: obesity-induced hypertension: new concepts from the emerging biology of obesity. Hypertension. 1999;33:537-41.
12. Eikelis N, Schlaich M, Aggarwal A, Kaye D, Esler M. Interactions between leptin and the human sympathetic nervous system. Hypertension 2003;41(5):1072-9.
13. Kizer JS, Nemeroff CB, Youngblood WW. Neurotoxic amino acids and structurally related analogs. Pharmacol Rev. 1978;29(4):301-18.
14. Dawson R, Annau Z. A behavioral assessment of arcuate nucleus damage after a single injection of monosodium glutamate. Neurobehav Toxicol Teratol. 1983;5:399-406.
15. Dawson R Jr, Wallace DR, Gabriel SM, A pharmacological analysis of food intake regulation in rats treated neonatally with monosodium L-glutamate (MSG). Pharmacol Biochem Behav. 1989;32:391-8.
16. Hirata AE, Andrade IS, Vaskevicius P, Dolnikoff MS. Monosodium glutamate (MSG) - obese rats develop glucose intolerance and insulin resistance to peripheral glucose uptake. Braz J Med Biol Res. 1997;30:671-4.
17. De Mello MA, de Souza CT, Braga LR, dos Santos JW, Ribeiro IA, Gobatto CA. Glucose tolerance and insulin action in monosodium glutamate (MSG) obese exercise-trained rats. Physiol Chem Phys Med NMR, 2001;33(1):63-71.
18. Pereira LO, Francischi RP, Lancha Jr AH. Obesidade: hábitos nutricionais, sedentarismo e resistência à insulina. Arq Bras Endocrinol Metab. 2003;47(2):111-27.
19. Remke H, Wilsdorf A, Müller F. Development of hypothalamic obesity in growing rats. Exp Pathol. 1988;33(4):223-32.
20. Rahmouni K, Haynes WG. Leptin and the cardiovascular system. Recent Prog Horm Res. 2004;59:225-44.
21. Hall JE, Brands MW, Dixon WN, Smith MJ, Obesity-induced hypertension: renal function and systemic hemodynamics. Hypertension. 1995;25:994-1002.
22. Haber RS, Weinsein SP, Role of glucose transporters in glucocorticoid-induced insulin resistance. GLUT4 isoform in rat skeletal muscle is not decreased by dexamethasone. Diabetes. 1992;41(4):728-35.
23. James DE, Jenkins AB, Kraegen EW. Heterogeneity of insulin action in individual muscles in vivo: euglicemic clamp studies in rats. Am J Physiol. 1985;248(11):E567-74.
24. Hamaoka K, Kusunoki T. Morphological and cell proliferative study on the growth of visceral organs in monosodium L-glutamatetreated obese mice. J Nutr Sci Vitaminol. 1986;32(4):395-411.
25. Machado UF, Shimizu Y, Saito M. Decreased glucose transporter (GLUT 4) content in insulin-sensitive tissues of obese aurothioglucose and monosodium glutamate-treated mice. Horm Metab Res. 1993;25:462-5.